Treatment Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Should men with castration-resistant metastatic prostate cancer receive further hormone therapy?

Posted by on Aug 21, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to discover the optimal timing of hormone therapies in combination with androgen-deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer. This study found that treatment with a second hormone therapy after prostate cancer becomes immune to hormone treatment is associated...

Read More

The safety and effectiveness of nilotinib in the treatment of unresponsive CML

Posted by on Aug 20, 2018 in Leukemia | 0 comments

In a nutshell This study examined the safety and effectiveness of using nilotinib (Tasigna) in patients with chronic myeloid leukemia (CML) unresponsive to other treatment. The study concluded that nilotinib is safe and effective in the treatment of CML unresponsive to imatinib (Gleevec). Some background Chronic myeloid leukemia is a cancer of the...

Read More

What is the evidence for and against green tea and tumeric in the management of CLL?

Posted by on Aug 20, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the evidence for and against green tea and turmeric in the treatment of chronic lymphocytic leukemia (CLL). The study found that there is a lack of evidence of these treatments in treating CLL. Some background Complementary alternative medicine (CAM) are a commonly used group of practices and products that are...

Read More

Outcomes and management of CLL treated with venetoclax

Posted by on Aug 20, 2018 in Leukemia | 0 comments

In a nutshell This study examined the safety and effectiveness of venetoclax (Venclexta) in the treatment of chronic lymphocytic leukemia (CLL). Researchers found that venetoclax was safe and effective in these patients. Some background Chronic lymphocytic leukemia is a type of cancer of the bone marrow that can lead to an abnormal immune system. Over...

Read More

Non-ergot dopamine agonists do not increase the risk of heart failure in patients with Parkinson´s disease

Posted by on Aug 20, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study investigated whether non-ergot dopamine agonists (DA) are associated with heart failure. Researchers suggested that DA therapy is not related to heart disease. Some background Levodopa is a main treatment option for Parkinson’s disease. Long-term use of levodopa, however, can lead to motor complications. Ergot and...

Read More

A 2018 update on Hodgkin lymphoma

Posted by on Aug 19, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This review paper analysed the current status of Hodgkin lymphoma research. Following this analysis, guidelines for the diagnosis and treatment of Hodgkin lymphoma were made. Some background Hodgkin lymphoma (HL) is a rare form of cancer which affects B cells (a type of white blood cell). It is necessary to determine which stage of the...

Read More

Breast cancer treatment with Tamoxifen and its relation to Fatty Liver Disease

Posted by on Aug 19, 2018 in Breast cancer | 0 comments

In a nutshell This study looked at the risk factors and protective factors surrounding non-alcoholic fatty liver disease in relation to tamoxifen (Novaldex) therapy for women with breast cancer. The authors found that a high BMI was a risk factor for tamoxifen related fatty liver disease, while exercise was a protective factor. Some background...

Read More

Evaluating vascular safety of TK inhibitors in patients with chronic myeloid leukemia

Posted by on Aug 18, 2018 in Leukemia | 0 comments

In a nutshell This study investigated the vascular (blood vessels) side effects associated with tyrosine kinase inhibitors in patients with chronic myeloid leukemia (CML). This study concluded that patients treated with nilotinib (Tasigna) experienced more vascular side effects. Some background Tyrosine kinase (TK) inhibitors are the standard therapy...

Read More

Evaluating the link between atrial fibrillation, anticoagulant treatment and the risk of stroke

Posted by on Aug 18, 2018 in Stroke | 0 comments

In a nutshell This study looked at the association between anticoagulant medication used in patients with atrial fibrillation (AF, irregular heartbeat) and its association with stroke. The authors found that AF is commonly undertreated which can impact the risk of stroke. Some background Atrial fibrillation (AF) is one of the highest risk factors...

Read More

An investigation into the effects of Hodgkin lymphoma on cognition

Posted by on Aug 17, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the effects of chemotherapy on cancer-related cognitive impairment in patients with Hodgkin lymphoma. The main finding was that patients with Hodgkin lymphoma who have been treated with chemotherapy experienced more cognitive decline than individuals without. Some background Chemotherapy is commonly used to treat...

Read More